TERT and clear cell renal carcinoma: To assess whether the 5′ UTR mutations were recurrent, we screened the promoter and 5′ UTR of TERT in an additional 377 samples from 94 patients with clear cell renal cell carcinoma by capillary sequencing (Table S4).